ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000906.1|Heme_1 # 3 # 407 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.523	BGC0000906.1|Heme_1 	3	407	+	Loose	380	25.409	AcrS	26.42	3000656	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	CTGCGGGAGCGCGTGTTGCACATGGTACGGGTCCGTGAGGCCCAAGAAGAAACGAAGGGTTTTACCGCGTTTATTCCTTGGAGTTTTCAGCCTAAGAACACTTCCTTGGAAGGAAATGCGTCGAGCGGTGTGGAATATCTAAAAACGCTCGCTGTATCTCGACTGATGTTGGATAATGTGCCGAACATTCAGGCTTCATGGGTAACCCAGGGAGCGAAGATGGCGCAAGTCGCTTTGGCTTTTGGTGCTAATGATTTTGGCGGAACCATGCTTGAGGAAAATGTTGTCCGTGCCGCCGGTGTGACCAATCGGGTACCTATGGAGGAAATTCTGCGGGCAATTCGTGATGCCGGCAAGGTACCGACGCAACGCGATACGCTCTACCGTATTCTCCGGGAGTTCTGA	LRERVLHMVRVREAQEETKGFTAFIPWSFQPKNTSLEGNASSGVEYLKTLAVSRLMLDNVPNIQASWVTQGAKMAQVALAFGANDFGGTMLEENVVRAAGVTNRVPMEEILRAIRDAGKVPTQRDTLYRILREF	MAKRTKAEALKTRQELIETAIAQFAQHGVSKTTLNDIADAANVTRGAIYWHFENKTQLFNEMWLQQPSLRELIQEHLTAGLEHDPFQQLREKLIVGLQYIAKIPRQQALLKILYHKCEFNDEMLAEGVIREKMGFNPQTLREVLQACQQQGCVANNLDLDVVMIIIDGAFSGIVQNWLMNMAGYDLYKQAPALVDNVLRMFMPDENITKLIHQTNELSVM	60.91	gnl|BL_ORD_ID|601|hsp_num:0	520			315	474	tigecycline; ciprofloxacin; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000906.1|Heme_2 # 425 # 1195 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AGGAG/GGAGG;rbs_spacer=11-12bp;gc_cont=0.467	BGC0000906.1|Heme_2 	425	1195	+	Loose	800	25.7942	MuxA	32.43	3004073	protein homolog model	n/a	n/a	macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACCAATTCAAAAATCTTGCCAGGTACTGCGACGAATCCCGATGATCATGCCATGCCGTTGATGGATCACTTAGAGGAACTCCGGAGCGTGTTGATCTTTTCCCTGGTGGCGTTGTTGCTCGGTGCGATCAGTGCCTATAACTTTCATCAGGAATTGATCGCATTGTTGATTCGTCCTTTGACGGAACTGGAGATTAAACCCGTCATTGTCCGGGCGACAGAAGGTTTTTTTGCTGCCTTAAAAGTGTCTGCTTTTGCCGGTCTGGTGATTGCATCGCCGGCGATCCTCTGGAAAATCTGGTCCTTTATCGTTCCTGCCCTTTATTCCCATGAACGGCGCTATGTCTACATTTTTTTCCCCTTTTCCGTGCTGCTATTTTTGTCAGGTGTGGCTTTTTCGTATATGACCGTGTATCCGCTCGGTGTCAAGTTCTTGATCACCTTTGGTGATTTTACGCCGATGATTTCGATCAGTGAATTTCTGGGTTTTGCCTTAACCTTTATATTACCCTTTGGTATCATTTTTCAACTGCCGGTGATCTTAATTTTTCTGGCGCGGATGGGCTTGATCACCCACCAATTGCTGGCAAAGTATCGCCAGTATGCGTTGTTGGCGATGTTTGTCATCGCTGCGGTGATTACGCCGACACCGGATATTGTGACCCAAACCTTGATGGCCTTGCCGATGTATTTGTTGTATGAGATCAGTATCTGGATGATCCGTTTGATTCGGCCGAAAAAAAAGACGTTGCCGGAAGATCGTGCATAG	MTNSKILPGTATNPDDHAMPLMDHLEELRSVLIFSLVALLLGAISAYNFHQELIALLIRPLTELEIKPVIVRATEGFFAALKVSAFAGLVIASPAILWKIWSFIVPALYSHERRYVYIFFPFSVLLFLSGVAFSYMTVYPLGVKFLITFGDFTPMISISEFLGFALTFILPFGIIFQLPVILIFLARMGLITHQLLAKYRQYALLAMFVIAAVITPTPDIVTQTLMALPMYLLYEISIWMIRLIRPKKKTLPEDRA	MTPTTGKSKFRTLRPWLITALAFAAVIGLVMWLAAPASAPSSDGRPGRGGKPGAALPKANALTVGVARVEQGDLALHFNALGTVTAFNTVNVKPRVNGELVKVLFQEGQEVKAGDLLAVVDPRTYKAALAQAEGTLMQNQAQLKNAEIDLQRYKGLYAEDSIAKQTLDTQEAQVRQLQGTIRTNQGQVDDARLNLTFTEVRAPISGRLGLRQVDIGNLVTSGDTTPLVVITQVKPISVVFSLPQQQIGTVVEQMNGPGKLTVTALDRNQDKVLAEGTLTTLDNQIDTTTGTVKLKARFENADGKLFPNQFVNVRLLAQTLKGVLTIPANAVQRGTNGIYVYVVGADNKVSQRSVAIGTSENERVVVESGLKAGEQVVVEGTDRLRDGMEVRVAEASPQVLEGEPQKPQTGRPSGLQGDSVGSGSAE	60.09	gnl|BL_ORD_ID|2242|hsp_num:0	2717			642	729	erythromycin; tetracycline; novobiocin; aztreonam; kitasamycin; rokitamycin
BGC0000906.1|Heme_3 # 1322 # 1942 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.506	BGC0000906.1|Heme_3 	1322	1942	+	Loose	400	26.5646	tetB(P)	20.27	3000195	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGCGCCTTTTTTTTGCTATCACATTGCCGGAAACGGTAACCAAAGCATTGACCGATCTGCAGTGGCGGGTACGGTTTCAACTGAAGCGAGGCAACTATACGCAGCCCGATAACTTCCATATTACTGTTGCCTTTTTGGGCGAGCAACCGGACGATGTGCCGGACTTGCTTATTCCCCCCCTAAATGCCCTGGCCAAATACACATCCCCTTTTTCGTTGACCCTTGACGGAATGGGGCGTTTTGGTTATGGCAATCCTTTTCGTGCCCTCTGGATGGGGGTTCAAGGTGAACGGACGCGGCTCAATTATCTTCAGGAAACCGTAAGTATGATCTGTGAAGTTTTAGGCTATCCCACGGAAGAGCGTCATTATCGGCCCCACGTGACATTAGTGCGCCATGCGGTTTTTCCGCCTAATACGGAAGAAGTGATGACCTGGACCATTCCCCGGAATAAAGCAACCTTTAAAGTAAATCACTTTGTATTGATGGAAAGTGTGACGCAGCATGGTCGCGTGGTTTATCGCCCTGTCCATACGTTTCACTTCGGGTTACCCGAATCGGCACGTATTCTCATGCCCGGCCCAACCATCAACGCCGGGACCGATGAGCGAGATGTATGA	MRLFFAITLPETVTKALTDLQWRVRFQLKRGNYTQPDNFHITVAFLGEQPDDVPDLLIPPLNALAKYTSPFSLTLDGMGRFGYGNPFRALWMGVQGERTRLNYLQETVSMICEVLGYPTEERHYRPHVTLVRHAVFPPNTEEVMTWTIPRNKATFKVNHFVLMESVTQHGRVVYRPVHTFHFGLPESARILMPGPTINAGTDERDV	MKKIINIGIVAHVDAGKTTITENLLYYSGAIKSVGRVDLGNTQTDSMELERKRGITIKSSTISFNWNNVKVNIIDTPGHVDFISEVERSLNSLDGAILVISGVEGIQSQTRILFDTLKELNIPTIIFVNKLDRIGANFNKVFEEIKKNMSNKVVRLQEVYDVGSKAVYIKKLFDTCIINDDAINVLSDLDEAFLERYIGGIEPDKEEIQEKLSLYAREGSLYPVFCGAAAIGLGIEDLLDGICSYFPFASNDCESDLSGVVFKIERTSKNEKKVYVRLFGGKISVRDKIQVPNKEIAEKVKKINRLENGGVVEAQRIEAGDIGILYGLTSFQVGDVIGISNDKIKNISIAKPALKTTISAIDKEKNPELFKALTLLAEEDPLLAFAMNDIDKEIYVNLFGEVQMEILSSMLDDLYGIKVEFSNIETIYKETPKGFGASIMHMQEDLNPFWATVGLEIEPAGRGEGLRYISNVSVGSLPKSFQNAIEEAVIKTSKQGLFGWEVTDVKVTLSCGEFFSPASTPADFRNVTPMVFMEALYKAQTVLLEPLHEFELKIPQNALSKAVWDLETMRATFDNPIVIGDEFSIKGLIPVENSKEYKMKIASYTEGRGMFVTKFYGYKEASAEFSKARKKTTYDPLNKKEYLLHKLNAIRD	31.60	gnl|BL_ORD_ID|737|hsp_num:0	804			1452	1674	tetracycline; doxycycline; minocycline; chlortetracycline; demeclocycline; oxytetracycline
BGC0000906.1|Heme_5 # 3133 # 4488 # 1 # ID=1_5;partial=00;start_type=TTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.525	BGC0000906.1|Heme_5 	3133	4488	+	Loose	500	26.9498	MYO-1	31.19	3006954	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	MYO beta-lactamase	TTGTCGAACCAAACATGGACCGATCGTGCTTGGAATTTTTTCAGCTCTATGAAACTTGGCTTGATTCTCTTGCTGGTGATTGCCGTAGCGGCTATCGCCGGCACCGTGATTCCACAGAATCAACCGCCTCAGGCTTACGGTTCTTCTTATGAGTTATATGATGCCCTTGGCTTAACTGACATGTATCATACCTGGTGGTTTTTAGTGCTCTTGGCGCTTTTGTCTATGAACCTGCTGGTTTGTTCCGTTCACCGCTTTGGTGCCTTACAGCGTCAATTCAGTGCTTTGCCGGCCGCTAAAAAAGCGGAAGACTTGCGCAGTCTGGCTACGAAAGCGACCAGTGTTCAACCGGGATCGGTCGATGCGGTAGCAGCGACGATCGCTACGCGCTGGCAGCAGGCAGGCTATCGTGTTCAACGCCAAAGTGATGGTGAGACGCAACTGATTGCCGCCGACAAAGGCCGTTGGGGTATCTGGGGTTCCTTAATTACGCACCTGGGGATGCTCGTGTTGCTGGCCGGTGCCGTTGTCAGTACATACATGTCAACGGAAGATCAAGCGCCCTTGGAAGTGGGCCAACAAGTGGCACTGTCGGAACTGGGAGGACTTTTAGGTGCGCCGTCCAATGTGGCGATCCAAGTCAAAGATTTTAAAACGATCTACCGCGAAGACGGAACGATCCAGGATTGGCTCAGTACCTTGACGGTGCTGAAAGACGGTCAGGAACAACTTACCCAGACGATTGAAGTGAACCAGCCCCTCTACTATGAAGGTTATAAATTCTATCAGGCTTTTTACGGTGCCAACATGGTGACTCATGTTACCGGCCCGAACGGAGAAAGCCGGGATGTGCGTTTGGAAGAAGGCGAAGCCGTTCAGGTACCTGGCACGAAGCTGGCCGTTATGCTCTATCGTTATGTGCCTGATTTTGATCCGGCCATCGCGCCCCAAACGAAATCGAATGAGCCGAATAACCCACGCGTCATCTATGTGGTCTATGAAGGCATGAAGCAGATTGACGTCGGTGCCGCACAGATCGGTGTACCGGAGACTTTGCCCGGTGGAGCCACCCTGGGCATCGTGAGCCATCGTCCCTATACTGGTTTGTTGATCCGACAAGATCCTGGTGTCAATATCGTCTGGCTCGGTTGCGCGATCCTGCTGGTGGGGATGGGACTTTCCTTTTACTTGCCCTACCGACGGATTTGGGCAGCGATAGAACCAAAGGGTGCTCAAGCGACCATCGCTTGGGCCGGGATTTCGCCCAAAAACAAAGTCGCTTTTGTAGATGAATTTCATCGCTTGACGGAAACAAAACCGGACGTAGCAAAGGAGAACGACGATGGGCTGGAGTGA	MSNQTWTDRAWNFFSSMKLGLILLLVIAVAAIAGTVIPQNQPPQAYGSSYELYDALGLTDMYHTWWFLVLLALLSMNLLVCSVHRFGALQRQFSALPAAKKAEDLRSLATKATSVQPGSVDAVAATIATRWQQAGYRVQRQSDGETQLIAADKGRWGIWGSLITHLGMLVLLAGAVVSTYMSTEDQAPLEVGQQVALSELGGLLGAPSNVAIQVKDFKTIYREDGTIQDWLSTLTVLKDGQEQLTQTIEVNQPLYYEGYKFYQAFYGANMVTHVTGPNGESRDVRLEEGEAVQVPGTKLAVMLYRYVPDFDPAIAPQTKSNEPNNPRVIYVVYEGMKQIDVGAAQIGVPETLPGGATLGIVSHRPYTGLLIRQDPGVNIVWLGCAILLVGMGLSFYLPYRRIWAAIEPKGAQATIAWAGISPKNKVAFVDEFHRLTETKPDVAKENDDGLE	MKILLAFFLLSSLTFISCKESSSNHNQANQENKKEIINKPLTDSLIVYQTENLIINKLSNHIYEHISFLNTDDFGKVACNGMLVLNENKVVVFDTPTDDKSSLELINFVTNTLKSEIIGLIPTHFHDDCIGGITEFENHNIQTYVSKETIELLKDNGQEFSNPTKDFDNSLTLDIGNKKVYAEYFGEGHTKDNVVGYFPEDNAVFGGCLIKEIDASKGYLGDANIKEWSTTVEKVKLKYPNAKIVIPGHGKWGGIELFDYTIKLFE	169.55	gnl|BL_ORD_ID|3706|hsp_num:0	4776			240	558	
BGC0000906.1|Heme_6 # 4475 # 5320 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.519	BGC0000906.1|Heme_6 	4475	5320	+	Loose	550	28.8758	BEL-1	30.26	3002385	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam	antibiotic inactivation	BEL beta-lactamase	ATGGGCTGGAGTGAAAATCTGCTTTTTTATTTGACATTTGCTCTTTATGGTATTGCGTCATTGCTTTATGTATCTTACTTGGCTTTGCGTAAGCCCTATCTGGCGCAAAGCGGGTACTGGATCACGGTGGCTGCAGTTACAACGAATACAGCCGCCCTGGTATTGCGCTACTTGATCGCCGGCTACTTGCCCTTGACGAACGGCTATGAGTTCTTGCTGGCCTTTTCCTGGGGGATTGCGGCCACTTATCTAATTGCCGAGCGCTATTACCGCATTCCTTTGGCCGGTGCTTTTGTCGTCCCTGTGGCTTGGCTGATTTTAGCGTACGTGGCGATGCTGATGGACCCGGTATCGCGGGCCAGTCGTCCGCTCATGCCGGCATTGCAATCGAATTGGCTGACCTATCACGTGATCACGGCCATGGTGGCCTATGGTGCCTTTGCTTTTTCCTTTGGTGTCGGTGTTATGTACTTATGGAAAAAAAGCGCCATCAAATCAGGGCGCACAACCGGTATCGGCGCACACTTGCCGTCGCCGGAACGTCTTGATGAGATCGGCTATCGCTTGATTGCAGCAGTCGGTTTTCCCCTGTTGACCCTTTGTATCATCACCGGCGCGATCTGGGCGGAATTTGCTTGGGGTCGCTACTGGGCTTGGGATCCCAAAGAGACGTGGTCAGCGATTACTTGGTTAATTTATGCCGCCTATCTGCATGCGCGCCATACCTTTGGGTGGCGTGGTAACCGTGCTGCATGGATGGCCATTATCGGTTTTATGGCGGTGTTGTTTACTTTCTTTGGCGTCAACTATTTTCTCACTGGTTTGCACGCCTATGCGAAAAGCTGA	MGWSENLLFYLTFALYGIASLLYVSYLALRKPYLAQSGYWITVAAVTTNTAALVLRYLIAGYLPLTNGYEFLLAFSWGIAATYLIAERYYRIPLAGAFVVPVAWLILAYVAMLMDPVSRASRPLMPALQSNWLTYHVITAMVAYGAFAFSFGVGVMYLWKKSAIKSGRTTGIGAHLPSPERLDEIGYRLIAAVGFPLLTLCIITGAIWAEFAWGRYWAWDPKETWSAITWLIYAAYLHARHTFGWRGNRAAWMAIIGFMAVLFTFFGVNYFLTGLHAYAKS	MKLLLYPLLLFLVIPAFAQADFEHAISDLEAHNQAKIGVALVSENGNLIQGYRANERFAMCSTFKLPLAALVLSRIDAGEENPERKLHYDSAFLEEYAPAAKRYVATGYMTVTEAIQSALQLSDNAAANLLLKEVGGPPLLTKYFRSLGDKVSRLDRIEPTLNTNTPGDERDTTTPMSMAQTVSKLIFGDTLTYKSKGQLRRLLIGNQTGDKTIRAGLPDSWVTGDKTGSCANGGRNDVAFFITTAGKKYVLSVYTNAPELQGEERALLIASVAKLARQYVVH	99.29	gnl|BL_ORD_ID|929|hsp_num:0	1008			306	495	
BGC0000906.1|Heme_7 # 5336 # 5968 # 1 # ID=1_7;partial=00;start_type=TTG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.536	BGC0000906.1|Heme_7 	5336	5968	+	Loose	600	28.1054	Streptomyces venezuelae rox	33.33	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	TTGTATCCGTTGATGCTGAAATTAGAAGGTCAACCTTGCCTGGTCGTCGGCGGTGGTACGATTGCGGAGCGAAAAATTGCTTCGTTGCTGGAGCATGGTGGACGTGTCCTGGTGATCACACCGGAAGCTTCCGATAAGATTCACCGGTGGGCTGAGAACGGTGAGGTTCGCTTGCTGCAGCGAACCTACCGGGAAGGTGACGCGGTTGGCCATTTTCTGGTTGTCGCCGCGACGAATGTCCCCGATGTTAACGCTTCGGTGGCTCGTGACTGTCAACAGCGCAATATTCTCATCAATGCCGTCGACAACCAAGAGTTAAGCAACTTTTTTGTACCGGCCAGTGTGCGTCGAGGTGATCTGACGATCGCCATCTCCACAGGCGGTGCCAGCCCGGCCGTAGCCAAGCGCATTCGCCGGGAGATCGAAGGTGTCTTCGGCGAAGAATATGCGGATTTTCTTAAAATCATGGCCGAACTGCGTGAGCAAGTATTGCGTGATGTTCCCGATCCCGCACGGCGTAAAGCGATATTTGATCGGCTGGCTGATGCAGGTTTACTGGCACTGCTCAAAGCAGGTGACCACCAAACGGTAAAGGAGCGAATTGCTCAGTGTTTATCTTTGTCGTCGGATTAA	MYPLMLKLEGQPCLVVGGGTIAERKIASLLEHGGRVLVITPEASDKIHRWAENGEVRLLQRTYREGDAVGHFLVVAATNVPDVNASVARDCQQRNILINAVDNQELSNFFVPASVRRGDLTIAISTGGASPAVAKRIRREIEGVFGEEYADFLKIMAELREQVLRDVPDPARRKAIFDRLADAGLLALLKAGDHQTVKERIAQCLSLSSD	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	44.12	gnl|BL_ORD_ID|4833|hsp_num:0	5820			9	252	rifampin; rifaximin; rifapentine
BGC0000906.1|Heme_8 # 5944 # 7239 # 1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=AGGAG/GGAGG;rbs_spacer=11-12bp;gc_cont=0.509	BGC0000906.1|Heme_8 	5944	7239	+	Loose	400	25.7942	catB9	21.05	3002681	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	GTGTTTATCTTTGTCGTCGGATTAAATCACAAATCAGCGCCCGTCGAAATTCGCGAGCAGCTTACCTTTTCGGAATCGACGATCGGCAAAGCCTTGGATCTGCTGTACAGTGAACCAGGGATTACCGGTTGTGCGATCTTATCGACATGCAACCGTACCGAGATCTACGGCTCGACGACGGATATCGAAAAAGGCTTGGCTGCTGTGCGGCGCTTTGTAACGAAAATGGGGCCGCTGGCGATCGAGAACTTCGCCAACTATTTTTATACCCATACCCTTTATGATGCGATTCGCCATCTCTTTCGTGTAGCTTCCGGACTGGATTCAATGGTGCTCGGTGAAACACAGATCCTCGGGCAGGTGCGCCGGGCTTACCAACTGGCCACTGAGCATGGCGTATCGAACAGTGTTGTTAACACTTGGTTTCAACAAGCCATCACGGTGGGTAAGCGGGTGCGTACCGAAACCGGTATTGATCAGCATGCCGTGTCCACCTCCTATACAGCGGTTGAACTGGCCCGGCAAGTGTTTAACGATCTCAACGGCAAAACAGCCTTGATTCTTGGGGCCGGTAAAATGAGCGAATTGACGTTGACCCACCTGATTGCCAATGGCGTTTCGACAGTCCTGGTGGCCAATCGCTCTTTCCAGAGAGCGGAAGAACTGGCCGGACGTTGCGGCGGGGAAGCCATCCACTTTGATAAGCTTGAAGAACGCATGCATGAGGCTGACATCGTGATTTCCTGTACGGCGGCTACGCACTATGTGATCCGCCGGGATATGGTGGAGCGGGTAATGGCCACGCGGAAGGAACGGCCGATTTTCTTTATTGATATCGCTGTTCCTCGCGACATAGAGCCCTCGGTAGGTACCGTTGGCGGTGTTCATCTTTTTGACATTGATGATTTGCAAAATGTTATCGATCAGAATTTAGCTGAGCGCAGCAAAGCAGCGGCGCTAGCAGAAGTGATCATCGATCAAGAGATTAACGATTTTCTTAAATGGCTCAACTCCCTTTTTGTCGTGCCGACCATCGTGGCTTTGAAAGCCAAAGGTGAAGAAGTCCGCAAAAAAGAGCTGGAGCGCGTTCTCGGACGCATGAAGGACCTTCCTGAAAAAGACCAAAAAACGATCAGCGCCTTGGCCTCATCGATTGTCAACCAATTGCTGCACGATCCGATTACCCAAATCCGGCATTACGCCGCTTCTCCCGATGGACATTTGTACTCGGAGATTTTGCAAAACCTCTTTGGTTTAGCCATTTCCGGACAACGTGCCAAAGGCAAAAGCGAGTAA	MFIFVVGLNHKSAPVEIREQLTFSESTIGKALDLLYSEPGITGCAILSTCNRTEIYGSTTDIEKGLAAVRRFVTKMGPLAIENFANYFYTHTLYDAIRHLFRVASGLDSMVLGETQILGQVRRAYQLATEHGVSNSVVNTWFQQAITVGKRVRTETGIDQHAVSTSYTAVELARQVFNDLNGKTALILGAGKMSELTLTHLIANGVSTVLVANRSFQRAEELAGRCGGEAIHFDKLEERMHEADIVISCTAATHYVIRRDMVERVMATRKERPIFFIDIAVPRDIEPSVGTVGGVHLFDIDDLQNVIDQNLAERSKAAALAEVIIDQEINDFLKWLNSLFVVPTIVALKAKGEEVRKKELERVLGRMKDLPEKDQKTISALASSIVNQLLHDPITQIRHYAASPDGHLYSEILQNLFGLAISGQRAKGKSE	MNFFTSPFSGIPLDQQVTNPNIIVGKHSYYSGYYHGHSFDDCVRYLHPERDDVDKLVIGSFCSIGSGAVFMMAGNQGHRSDWISTFPFFYQDNDNFADARDGFTRSGDTIIGHDVWIGTEAMIMPGVKIGHGAIIASRSVVTKDVAPYEVVGSNPAKHIKFRFSDVEIAMLLEMAWWNWPESWLKESMQSLCSSDIEGLYLNWQSKART	206.22	gnl|BL_ORD_ID|91|hsp_num:0	106			87	255	azidamfenicol; chloramphenicol; thiamphenicol
BGC0000906.1|Heme_9 # 7265 # 8212 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.577	BGC0000906.1|Heme_9 	7265	8212	+	Loose	700	28.1054	PDC-396	30.49	3006765	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin	antibiotic inactivation	PDC beta-lactamase	ATGACTGAAATCAATCGCCCCATCGTCATCGGCACCCGCGACAGCGCCCTGGCCCTCTGGCAAACCCATTGGGTTTTGGAACAACTGCAAGCTCGTTTTCCGGAGCAGCGCTTTGAAATCAAAGCGATCAAAACCAAAGGGGACAAGATCCTCGACGTCGCCCTCGCTAAAATCGGTGATAAAGGCCTTTTCACCAAAGAGCTGGAAGTGGCGATGCTGGAAGGCGAAGTGGACATGGCTGTGCATTCGCTGAAAGATCTCCCCACGCAACTGCCTGAAGGTCTGACCGTCGGTGCCATGTGCATCCGTGAAGACTACCGGGATGTACTCATCGGTCGTACGGCCCGCACCTTGGCGGAACTGAAGCCAGGCGCACGAGTCGGCACGGCCAGCTTGCGCCGCAAATCGCAGATCTGGAAAGTTCGCCCCGATCTCGAACTGCTCGATATCCGCGGCAACCTGCAGACGCGGATGCGCAAGATGGAAGAACAAGATTTAGACGGTATCATTCTCGCGGCGGCTGGCGTCCTGCGGCTCGGTTGGGCTGACAAGATCACCCAGTACATCGATGAGGATGTTTGTTTACCGGCCGTCGGCCAGGGTTCAGTGGGCATCGAAATCCGTGACGGAGACGAAGCCATTGCCCGCGTCGTCGGCGCCCTCAACCACAAGGATACTGCCGATTGCATTACGGCAGAACGCGCGTTGATGCGCACCTTGGAAGGGGGATGCCAAGTACCCATCGGTGCCCTGGGCAAACTCGGCGAAGACGACAGCTTAACCCTGCATGGTGTGGTTGCTTCGCTGGACGGTCGCGAGATTTGCCGCGATCAAGTTACCGGTCACAGAAGCGAGGCGGCCGATCTCGGTCATCGCCTGGCCGATATCCTCATCGCCAAGGGAGCCGCAGAAATTCTAAAAGCTGTAAGACAGGAGTCGTGCAACTGA	MTEINRPIVIGTRDSALALWQTHWVLEQLQARFPEQRFEIKAIKTKGDKILDVALAKIGDKGLFTKELEVAMLEGEVDMAVHSLKDLPTQLPEGLTVGAMCIREDYRDVLIGRTARTLAELKPGARVGTASLRRKSQIWKVRPDLELLDIRGNLQTRMRKMEEQDLDGIILAAAGVLRLGWADKITQYIDEDVCLPAVGQGSVGIEIRDGDEAIARVVGALNHKDTADCITAERALMRTLEGGCQVPIGALGKLGEDDSLTLHGVVASLDGREICRDQVTGHRSEAADLGHRLADILIAKGAAEILKAVRQESCN	MRDTGFPCLCGIAASTLLFAATSAIAGEAPADRLKTLVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASLHWPALQGSRFDGISLLDLATYTAGGLPLQLPDSVQKDQAQIRDYYRQWQPTYTPGSQRLYSNPSIGLFGYLAARSLGQPFERIMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANLHPERLDKPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR	79.35	gnl|BL_ORD_ID|4455|hsp_num:0	5525			243	489	
BGC0000906.1|Heme_10 # 8212 # 9750 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=AGGAG/GGAGG;rbs_spacer=11-12bp;gc_cont=0.543	BGC0000906.1|Heme_10 	8212	9750	+	Loose	590	26.1794	HERA-4	32.73	3004819	protein homolog model	n/a	n/a	penam	antibiotic inactivation	HERA beta-lactamase	ATGAATCAAAAGGTAGGGAAAGTTTATCTCGTAGGTGCGGGACCAGGGGATCCCGGCTTGATCACCGTCAAAGGCTTGCAATGTATTCAAAAAGCCGACGTTCTCGTTTATGATCGCCTCGCCGGTCACCGCCTGCTCACATATGCCCGCCCTGACGCGGAGTTGATCTTCGTCGGCAAAGGCCCGAACCTCCACGTATACAAACAAGAAGAAATCAACGAAGTGATCAAACAAAAGGGCCTGGAAGGTAAAATCGTTACCCGCTTAAAAGGCGGCGATCCCTTTGTTTTCGGTCGCGGCGGCGAAGAAGCAGAAGTGCTTCTGGAAGCCGGCGTACCTTTTGAAATCGTTCCCGGCATCACCTCGGCCATCTCAGTGCCTGCTTACGCCGGTATCCCTGTAACTCACCGCGATTTTACGGCTAACTTTGCTGTCATTACCGGCAACGAAGATCCCAACAAAGAAGAGTCCAACATTGACTGGGAAAAAATCAGCACCGGTATCGGTACGCTGGTCTTCCTGATGGGCATGGGCAACCTGCCGCACATCACGACCAAGCTGATCGAAAATGGCCGCGACCCGCAAACACCGGTGGCTTTGATCCGCTGGGGTACCCGTCCGGAACAGCGCACCATGACCGGTGTCATCGCCGACATCGCCGAAAAAGCCAAAGAAGCCAACTTCCAAAACCCGGCGATCATCATTGTCGGCGAAGTGGTCAAGCTGCGTGAAAAACTGGCATGGCTGGAGAAAAAGCCGCTCTTCGGCAAACGCATCGTCGTCACCCGTTCGCGCCAGCAAGCATCGGCTTTTGCCGGCCGACTGGAAGAACTTGGTGCGGAGCCGTGGGAATTCCCGACGATCGACATTCAAGAGCCGGCCGATCTCAAACCGCTCGATAATGCTATCGCGCACATCCAGGATTATTCTTGGATTGTCTTTACCTCGCCCAACGGCGTGGAACACTTCTTTAGCCACTATTTCTCGGCCGGTCATGACATCCGCGATCTGCAAGGCATCCAGCTTTGCGCCATCGGGCCGCAAACCAAAAAAGAAGTGCAAAAATACGGCCTGAAAGTCGACTATGTGCCGGAAGAGTTCCGTCAAGAAGCGATCATCGAAGGCTTGAAAAACTACGACTGGCAAGGCAAAAAAGTCCTGCTGCCCCGTGCGGACATTGCTCGTAAAGAACTGCCCGAAGCATTGGTACGCTTTGGTGCCATCGTTGATGACGTGGTGACCTACCGTACCGTTCGCGGCAGCGGCGATGCCGGCATCTTGAAGCAGATGATGAATGATAAAATGATCAGCGCCGTCACCTTTACTTCGTCATCGACAGCGCGTAACTTTGTGGAAATGCTTGGCGTGGAAGACGCTGCGGAACTGCAACGCCTCCTCGAAGGTGTTACCCTCGCTTCCATCGGTCCGGTCACTTCCGAAACGATGCGCGCCTTGGGCCTGCGTGTTGATGTGGAAGCCACCGAATACACCATCCCCGGCTTGACCAAAGCGCTGCTTGGCTTCTGGGGTATTCAGTAA	MNQKVGKVYLVGAGPGDPGLITVKGLQCIQKADVLVYDRLAGHRLLTYARPDAELIFVGKGPNLHVYKQEEINEVIKQKGLEGKIVTRLKGGDPFVFGRGGEEAEVLLEAGVPFEIVPGITSAISVPAYAGIPVTHRDFTANFAVITGNEDPNKEESNIDWEKISTGIGTLVFLMGMGNLPHITTKLIENGRDPQTPVALIRWGTRPEQRTMTGVIADIAEKAKEANFQNPAIIIVGEVVKLREKLAWLEKKPLFGKRIVVTRSRQQASAFAGRLEELGAEPWEFPTIDIQEPADLKPLDNAIAHIQDYSWIVFTSPNGVEHFFSHYFSAGHDIRDLQGIQLCAIGPQTKKEVQKYGLKVDYVPEEFRQEAIIEGLKNYDWQGKKVLLPRADIARKELPEALVRFGAIVDDVVTYRTVRGSGDAGILKQMMNDKMISAVTFTSSSTARNFVEMLGVEDAAELQRLLEGVTLASIGPVTSETMRALGLRVDVEATEYTIPGLTKALLGFWGIQ	MKKITPLFVIAFLTLIALLAPAQASVTPDMTDFLRQQEQRLHARIGMAVVNAQGETVFGYRQDERFPLTSTFKTLACAALLERLQKNGGSLDEQVTIPPDALLDYAPVTKNYLAPATISLRMLCAAAVSYSDNTAGNRILTYLAGPDAVTQFMRGIGDHVTRLDRTEPTLNEATPGDARDTSSPQKMAAGLQKILTSPPLISANRATLAQWMRDDKVGDALLRAALPKGWAIADKTGAGGYGSRAIIAAVYPPERPPFYVAIFITQTEASMKMANETTAEIGKQLFAGQP	176.55	gnl|BL_ORD_ID|2540|hsp_num:0	3613			354	516	
BGC0000906.1|Heme_11 # 9928 # 11106 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.545	BGC0000906.1|Heme_11 	9928	11106	+	Loose	500	26.9498	MSI-OXA	30.61	3003719	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	MSI-OXA family beta-lactamase	ATGATCGGTGTAACCAAACTGCTGACAGACTCCAACCATTTTGGCGATACCCTGCGCTACGCTCACGGTTCCCAAGGCCAAAAGAACGGCGCTGTTGCCGGTCACGGCCCTGTGGTCGCTTGGAACGTATCGCGGACTTGTAACCTGCACTGCATCCACTGCTATTCCGACTCCGATGAAATCGAGTATCCCGGCGAACTGACGACGGCAGAAGCGAAAAAGTTCATCGACGATCTGGCCGATTTTAACGTGCCCGTGCTGCTTCTTTCCGGTGGTGAGCCGCTGATGCGCCCTGACATCTTTGAGCTCGTGGAATACGCACGCAGCAAAGGTATCCGCACCACTTTCTCCACCAACGGTACGCTGATCACCCCCGAAGTGGCTGCCAAAATCAAAAGCCTGGAAGTTGGTTATGTCGGCATCTCCCTCGACGGCATCGGCGAAAACAACGACCGTTTCCGCGGTAAAGAAGGCGCCTTTGAAGATGCCCTCGCTGGTATCCGCAACTGTCTGGCTATCGGCCAACGGGTAGGCCTGCGCTTTACGATCAACCGTCACAACCTCAACGACATGGAAAACATCTTCCGCGTCATTGAAGAAGAAAAAATCCCCCGCGTTTGCTTTTACCACCTCGTTTACTCCGGCCGCGGCGGCGCCATGATGGCCGAAGATATCACCCATGAAGAGTCTCGCAAAGCGATGGACCTGATCATGGAAAAAGTTCTCGAATTCGAAGCCAAAGGGATCGACTGTGAAATCCTCACCGTCGACAACCACTGCGATATCGTTTACCTCTACCTGAAAATGAAAGACCGCTTCCCAGAAAAAGCCGAATACATCTGGAAGCTGATGCAAATCAACGGCGGCAACCGGACCGGTATCGCTTTCTCCAACGTGGACTCCCAAGGGAACGTTCACCCCGACCAGTTCACCCAAAACCACACCTTCGGCAACGTCAAAGAGCGTCCTTTCGGCGAAATCTGGACGGACACCTCGAAAAACGAAATCCTGGCCGGTCTCAAAGATCGCAAACCGCTGCTCAAAGGCCGCTGCGCCAAGTGCCAATGGCTCAACGTCTGCAACGGCAACTTCCGCGCTCGCGCTGAAGCGGTAACGGGCGACTTCTGGGAATCCGATCCCGCTTGCTACCTGACCGACGAAGAAATCGGCATTAAGTAA	MIGVTKLLTDSNHFGDTLRYAHGSQGQKNGAVAGHGPVVAWNVSRTCNLHCIHCYSDSDEIEYPGELTTAEAKKFIDDLADFNVPVLLLSGGEPLMRPDIFELVEYARSKGIRTTFSTNGTLITPEVAAKIKSLEVGYVGISLDGIGENNDRFRGKEGAFEDALAGIRNCLAIGQRVGLRFTINRHNLNDMENIFRVIEEEKIPRVCFYHLVYSGRGGAMMAEDITHEESRKAMDLIMEKVLEFEAKGIDCEILTVDNHCDIVYLYLKMKDRFPEKAEYIWKLMQINGGNRTGIAFSNVDSQGNVHPDQFTQNHTFGNVKERPFGEIWTDTSKNEILAGLKDRKPLLKGRCAKCQWLNVCNGNFRARAEAVTGDFWESDPACYLTDEEIGIK	MSHTFIIDRLGASMIKQILAALLLISPLLAQAAEWKESAQVARLFKQEGVSGTFVVYDVAADSYTVHDRQRANTRFIPASTFKIPNTLIALAHGAVANVDEVVPYGGKPVARPEWARDMGLREAIRISNVPVYQEVARRVGLDRMRSELVRMKYGNMQTGTVVDRFWLDGPLKISAVEQTEFLTKLAQGTLPFTNVAMAAVREISRQDGAPELYAKTGWGSRPGEADIGWWVGWLKKDGKLYAFALNMDLPDGAQDKRVSLAKAALRELGLL	144.12	gnl|BL_ORD_ID|2031|hsp_num:0	2234			291	420	
BGC0000906.1|Heme_12 # 11332 # 12321 # 1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.559	BGC0000906.1|Heme_12 	11332	12321	+	Loose	600	30.0314	rgt1438	47.5	3002883	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin glycosyltransferase	GTGAAATACATCGTACCTGGCTTCCCCATTCAGCGGATGCGCCGCTTACGGGAAAACCCCACGGTTCGGGAAATGGTTCGCGAAAATCATCTGCGTCCCGAAGACTTAATCTATCCGCTTTTCGTCGTTCCCGGCGAAAACGTCAACAATCCGGTCTCCTCGATGCCGGGCGTTTCCCAACTGTCCATCGACCTGCTCGTCAAAGAAGCCGTCGATGCCGTCAAAGCGGGCGTCAAGGCCGTGGAGATCTTCGGCATTCCCCCAGAAAAAGACGGATTCGGTTCCGGTGCGTACGATCCCAACGGCATCGTGCAAGAAGCCGTTCGTGCCGTCCGTAAAGCCTGTCCCGATCTGTACATCATCACTGACGTTTGCCTTTGCCAATTCACTGATCACGGTCACTGCGGCATCGTCGAAGGCCATCGCGTGCTCAATGATCCGACACTAGCATACCTGGGACGGGCTGCCGTTTCCCATGCACAGGCCGGTGCCGATATGGTCGCGCCTTCTGACATGATGGACGGTCGGGTCAGTGCGATCCGCGCCGCTTTAGATGAAGCCGGTTTCAATCATATCCCGATTATGTCCTACTCGGCTAAATATGCTTCGGCCTTTTACGGTCCTTTCCGTGAAGCAGCTGAATCGACGCCGCAATGGGGTGACCGCCGGTCCTATCAAATGGATCCGGGCAACTCCAATGAAGCGCTCCGTGAAACGGCTCTGGATATCCAGGAAGGCTGCGACATCATCATGGTCAAGCCGGGCCTGTCCTACATGGACATCATCTACCGCCTCAAGCAAGACTTTGGCATGCCTGTCGCCGTCTACAACGTTTCCGGCGAATACGCCATGGTCAAAGCGGCCGCGGCCAACGGCTGGATCGATGAGAAAAAAACCGTCTTGGAAATCCTGCTTAGCTTCAAACGGTCCGGTGCTGATATGATCATCACCTACCATGCCAAAGACGTTGTCCGCTGGCTGGCCGAGTAG	MKYIVPGFPIQRMRRLRENPTVREMVRENHLRPEDLIYPLFVVPGENVNNPVSSMPGVSQLSIDLLVKEAVDAVKAGVKAVEIFGIPPEKDGFGSGAYDPNGIVQEAVRAVRKACPDLYIITDVCLCQFTDHGHCGIVEGHRVLNDPTLAYLGRAAVSHAQAGADMVAPSDMMDGRVSAIRAALDEAGFNHIPIMSYSAKYASAFYGPFREAAESTPQWGDRRSYQMDPGNSNEALRETALDIQEGCDIIMVKPGLSYMDIIYRLKQDFGMPVAVYNVSGEYAMVKAAAANGWIDEKKTVLEILLSFKRSGADMIITYHAKDVVRWLAE	MRMLLTTYGSRGDVEPLAGLAAGLRKLGVEARVCAPPDEEFAALPARAGVPLIPLGPPVRPVVAGERPPTPQDAFRLAAELVTARFDTLTEAAEGCQAVLATGLMPAGVRDVAEKLGIPYVFACFHIYGLPSRHFPPGARPGTPPAPDGTDHRELWEQDARSVNALYGDALNRHRTGIGLPPVRNVRDHVLTDRPWLAADPVLCPAEGMTEFDLVQTGPWFLPDERPLPAGLEEFLGAGAPPVYVGFGSMGAYAPEGIARVAVEACRAQGRRVVLARGWAGLTPDDGGADCFAVGEVNQQALFRRVAAVVHHGGAGTTTTAARAGAPQVVVPRIADQPYWAERVRDLGIGSAHPDPVVTFDSLSAALTTALAPEVRARARTVAGTIRTDGASVAARLLVETADRAGRPVSP	80.05	gnl|BL_ORD_ID|116|hsp_num:0	134			681	801	rifampin; rifaximin; rifabutin; rifapentine
BGC0000906.1|Heme_13 # 12424 # 13416 # 1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.554	BGC0000906.1|Heme_13 	12424	13416	+	Loose	500	25.409	OXA-542	32.26	3005768	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGATCATTTCATGGAATACAACCAACCAGTGCAATATGTTCTGCGATCACTGCTACCGTGATGCCGGAGCCAAAGCCAGTGAAGAGCTTTCCACCGAAGAAGGCAAATCGCTGCTCGACGAGATCGCCAAAGCCGGCTTTAAGATCATGATCTTCTCCGGTGGCGAGCCGCTCATGCGCCCCGACATCGTCGAACTGGTGCAACATGCCACCAACCTGGGCCTCCGCTCGGTTTTCGGCACCAACGGCACCTTGATCACGCTGGAAATGGCTCAAAACCTCAAAAAAGCTGGCGCCATGGGCATCGGGATCTCCCTCGACTCGATGGACAAACAAAAACATGACACCTTCCGCCGCTATCCCAACGCCTGGGATGAAGCCGTCGAAGGCATGAAAAACTGCCGCGCTGCCGGCCTAGGCTTCCAGATCCACACGACTGTCATGGATTGGAATCGCCATGAGGTACATGCGCTGACTGACTTTGCCGTGGAAATGGGCGCTGTTGGCCACCACACCTTCTTCCTTGTACCGACGGGCCGCGCTGTTTCGATCGAAGAAGAGTCGCTGAAAGCCGAAGCCTACGAAGAGATCTTGACGGAGATCCTGGAAAAACAAAAAACCGTCGATATCGAACTGAAACCAACTTGCGCACCGCAGTTCATGCGTATCGCCAAGGAGATGGGCATGGATATGCGCTACAACCGTGGCTGCCTCGCCGGCACCCACTACTGCATCATCTCGCCGAAAGGCATTGTCCAGCCTTGCGCGTACCTGAACATTCCCGCCGGCAACGTCCGTGAAACGCCGTTCTCGCAGATCTGGAAAGAAGCACCGATCTTCAAAGAACTGCGCACCTTGGCCTACAAAGGTGGCTGCGGTTCTTGCAAATACAAATACGCTTGCGGCGGTTGCCGGGCTCGCGCTTACTACTACCACAACAACGACTTCATGGCTGAAGAGCCCTGGTGCCTCTATCACGGACGGAAGGGGTAA	MIISWNTTNQCNMFCDHCYRDAGAKASEELSTEEGKSLLDEIAKAGFKIMIFSGGEPLMRPDIVELVQHATNLGLRSVFGTNGTLITLEMAQNLKKAGAMGIGISLDSMDKQKHDTFRRYPNAWDEAVEGMKNCRAAGLGFQIHTTVMDWNRHEVHALTDFAVEMGAVGHHTFFLVPTGRAVSIEEESLKAEAYEEILTEILEKQKTVDIELKPTCAPQFMRIAKEMGMDMRYNRGCLAGTHYCIISPKGIVQPCAYLNIPAGNVRETPFSQIWKEAPIFKELRTLAYKGGCGSCKYKYACGGCRARAYYYHNNDFMAEEPWCLYHGRKG	MKKVVFPILSIFTLFSLNACSSVQTASESTISAYNQQSKETIKKYFDDAQTQGVIVIKDNNHLAIYGNNLTRAHTQYVPASTFKMLNALIGLENNKVTTDELFKWDGNKKAFPIWEKDMNLDEAMKLSAVPVYQELAKRIGIDLMQKEVKRVNFGNANIGTKVDNFWLVGPLKITPIQEVKFADDLAHNKLPFKIETQETVKNMLLIKEINGSKIYAKSGWGMDVTPQVGWLTGWVEQPTGKIISFSLNLEMKNNMTGSIRNEITYKALENLGII	120.00	gnl|BL_ORD_ID|3803|hsp_num:0	4873			339	432	cloxacillin; oxacillin; cefalotin
BGC0000906.1|Heme_15 # 14060 # 14539 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.519	BGC0000906.1|Heme_15 	14060	14539	+	Loose	500	25.0238	OXA-504	28.0	3005734	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGTGGACTGAAAAAGACAAAGAGCTTATTCGTCTTTTGCAAGATGATCTGCCGCTGACATCGCGTCCCTATCAGGCGATCGGTGAGCAAATCGGTCTCACTGAAGAGGAAGTACTGGCAGCAGTACAACGCCTAAAAGATACCGGTGCCATGCGCCGTCTTGGCGTAGCACTGCGTCACCGTGAAGTGGGCTATACGGCCAACGGTATGGGTTGCTGGAATGTACCGGAAGAAAAAGCCGATGAGATCGGCAAGATCATGGCCGGTTTTCGGGAAGTTTCCCATTGCTACCAGCGTCCCCGGTTTGAAGGCTGGCCCTACAGCCATTTTACAATGATTCACGGCACAACCCGGGAAGACTGCGAAGCCGTTGCCAAGCGGATTTCCGAAGCGACAGGCATCACCGATTACCGGTTGCTTTTCTCTACAGTGGAACTGAAAAAGACCAGCATGCGTTACTTCATGGAAAAAGAAGCGTAG	MWTEKDKELIRLLQDDLPLTSRPYQAIGEQIGLTEEEVLAAVQRLKDTGAMRRLGVALRHREVGYTANGMGCWNVPEEKADEIGKIMAGFREVSHCYQRPRFEGWPYSHFTMIHGTTREDCEAVAKRISEATGITDYRLLFSTVELKKTSMRYFMEKEA	MPRMLLSSLLAAGLFCALPASAASGCMLFADGTGKPVSTQGDCAAQLTPASTFKIPLALMGYDSGFLVDEQLPALPFKAGDPDFLPEWKQTTTPSSWMQFSVIWYSQRLTEWLGEARFQHYVDSFDYGNRDLEGNPGKHDGLTQAWLSASLAISPQEQARFLGKMVSGKLPVSAQTLRHTANLMRQPDIDGWQIHGKTGMGYPKLLDGSLDREQQIGWFVGWASKQDKTLIFVHTVIQTPGKQFASLRAREEVFAALPARLKTL	60.23	gnl|BL_ORD_ID|3769|hsp_num:0	4839			462	594	cloxacillin; oxacillin; cefalotin
BGC0000906.1|Heme_16 # 14552 # 15826 # 1 # ID=1_16;partial=00;start_type=TTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.576	BGC0000906.1|Heme_16 	14552	15826	+	Loose	1500	27.7202	LptD	24.36	3005059	protein homolog model	n/a	n/a	peptide antibiotic; aminocoumarin antibiotic; rifamycin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	TTGGCTCATCACGGCTATGAACGCTCGGAGGCAATGTTTGCTGAAGCGTTGAAAGTCATTCCCGGCGGCGTCAACTCGCCCGTGCGGGCATTTAAATCGGTCGGTCGTAACCCCGTGTTTATCGATCGGGCGAACGGTGCATACCTCTATGATGTGGACGGCAACCGCTATATCGACTATGTGCAATCATGGGGTCCCATGATCGTCGGTCATAACCATCCCGAAGTGGCGGAAGTGCTCAAAGCGGCTGTAGACCGGGGTACGTCCTACGGTGCGCCGACGGAACTGGAAACGAAGTTGGCCAACATGGTGCTGGAAGCGTTCCCGGCGATGGACAAGGTGCGTATGGTCAACTCCGGTACGGAAGCGACGATGAGCGCACTGCGTCTGGCTCGTGGTTTCACCGGCCGGAGCAAGATCGTCAAGTTTGAAGGCTGCTATCATGGCCATGCTGACAGCCTCTTGATCAAAGCCGGTTCCGGTGCGCTGACCTTTGGCGTGCCGACGAGCCCGGGGGTTCCGGCAAACATTGCCGCCAATACGATCACAGCACCTTATAATGACCTGGAAACGTTGCGGGAGATCTTTGCCCAAGTGGGCAGCGATATTGCGGCCGTGATCATTGAAGGTGTACCGGGCAACATGGGCGTTGTGCCGCCTCGTCCGGGCTACCTGCAAGGTGTACGCGAGCTGACCCAGGAGTTTGGCGCGCTGTTGATCTTCGACGAAGTGATGAGTGGCTTCCGCGTAGCTTACGGCGGAGCTCAGAGCCGGTATAAGATCGACCCCGATATCACCTGTCTCGGCAAAATCATCGGCGGTGGTCTGCCCGTCGGTGCTTATGGTGGTAAAGCGGAGATCATGGAGAAAATCTCGCCGGCCGGCCCGATCTATCAAGCCGGCACACTGTCCGGTAACCCCTTGGCCATGACGGCGGGAATTGCGACGCTGAATATCCTCAAGCGTCCCGGTACCTATGATGAGCTGGAGAAAAAAGCAGCTTATCTGGCCGATGGCTTAGCGCAAGCGGCGCAAGATGCCGGTGTAGCTGTGTCGACGAACCGCGTCGGGGCGATGTTTACAGGCTTCTTTACGGAACAGCCGGTCAATGATTTTGCTTCGGCCTTTACGTCTGATACGGAAGCGTTCGCGACCTACTTCCGGGCGATGCTTGACCGGGGTGTGTATCTGGCATGCTCGCAGTTCGAAGCGGCCTTTATGTCGCTGGCCCATACGCAGGAAGATCTGGATGCGACGATTGCGGCGCAGCAGTGA	MAHHGYERSEAMFAEALKVIPGGVNSPVRAFKSVGRNPVFIDRANGAYLYDVDGNRYIDYVQSWGPMIVGHNHPEVAEVLKAAVDRGTSYGAPTELETKLANMVLEAFPAMDKVRMVNSGTEATMSALRLARGFTGRSKIVKFEGCYHGHADSLLIKAGSGALTFGVPTSPGVPANIAANTITAPYNDLETLREIFAQVGSDIAAVIIEGVPGNMGVVPPRPGYLQGVRELTQEFGALLIFDEVMSGFRVAYGGAQSRYKIDPDITCLGKIIGGGLPVGAYGGKAEIMEKISPAGPIYQAGTLSGNPLAMTAGIATLNILKRPGTYDELEKKAAYLADGLAQAAQDAGVAVSTNRVGAMFTGFFTEQPVNDFASAFTSDTEAFATYFRAMLDRGVYLACSQFEAAFMSLAHTQEDLDATIAAQQ	MKKRIPSLLATMIASALYSQQGLAADLATQCMLGVPSYDRPLVEGRPGDLPVTINADHAKGNYPDNAVFTGNVDINQGNSRLRADEVQLHQQQAAGQAQPVRTVDALGNVHYDDNQVILKGPKAWSNLNTKDTNVWQGDYQMVGRQGRGTADLMKQRGENRYTILENGSFTSCLPGSDTWSVVGSEVIHDREEQVAEIWNARFKLGSVPIFYSPYLQLPVGDKRRSGFLIPNAKYSTKNGVEFSLPYYWNIAPNFDATITPHYMNKRGGVMWENEFRYLTQLGSGLTEFDYLPSDKVYEDDHSSDSNSRRWLFYWNHSGVIDQVWRLNADYTKVSDPDYFNDFSSKYGSSTDGYATQKFSAGYVNQNFDATVSTKQFQVFDRESSNSYSAEPQLDVNYYQNDVGPFDTHLYGQVAHFVNSNNNMPEATRVHFEPTINLPLSNGWGSLNTEAKLLATHYQQSNLDKYNAANGTDYKESVSRVMPQFKVDGKMVFERDLQEGFTQTLEPRVQYLYVPYRDQSEIGNYDSTLLQSDYTGLFRDRTYSGLDRIASANQVTTGLTSRVYDAAAVERFNISVGQIYYFTESRTGDDNINWENNDTTGSLVWAGDTYWRIADEWGLRGGIQYDTRLDNVATGNGTIEYRRDENRLVQLNYRYASPEYIQATLPSYSTAAQYKQGISQVGMTASWPIVDRWSVVGAYYYDTNTRKAANQMLGVQYNSCCYAIRLGYERKVNGWNSNDNGGESKYDNTFGINIELRGLSSNYGLGTQQMLRSNILPYQSSL	54.22	gnl|BL_ORD_ID|2784|hsp_num:0	3799			951	1128	
BGC0000906.1|Heme_17 # 16014 # 16949 # 1 # ID=1_17;partial=00;start_type=TTG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.515	BGC0000906.1|Heme_17 	16014	16949	+	Loose	550	29.6462	LRA-9	19.57	3002488	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	subclass B3 LRA beta-lactamase	TTGAAAAGAAGTTTTCTATCCTTCCTAACAACATCAGCCTTGTTGGCGTTAACGACAACAGCCTGGGCCGCACCTACCGTGACTGTTGATGGCCAAGCACTCGCTTTTGACGTGCCCCCCATCATCGAAAACGGCAGGACCCTGGTGCCGGTGCGGGCGATCAGCACGGCGCTGGGTGCCAACGTCAATTGGGATGTGGCCACCCAGACCGTAATCATCCAAAAAGCAGACAATAACATCCGCTTACCCCTCGGTGGTCAAGCCACCAAAAACGGCAATCCCATGGACCTTGATGTACCGGCTAAAATCATCCAAGATCGCACCATGGTTCCGCTACGATTTGTTTCCGAAGCCTTAGGGTGCCACGTCGTTTGGCATGACTCCACCCAAACCATTGCGATTACAGCGCAGGCCGAACCACAATCCCCATCGACGGCAACCAAAACCATAGACGAAAAAGATAACGGAAAAACGATCACGCGCTTCGCCTTCCTGACCAAACTGATCAAGGAGACCGACCTAAACCTCAATCACATTCGCTTCATCAAAGCGCCCGTTCCCAGCGACTACGTAACCGATGTTCCCCAGGAAGCCAGTTATGCTCACGATGTAGTCATCGCCGGACACTATAACATCATTGACATCGGACAAGCCTTCCGCCCCGATGATGCGATTACCCGTGAGGAAGCCGCCCTTTGGCTCGTAAAAGCATTGGAAAGTAAAAAAGGCTCCTTGATGTATATTCAACTTTTTCAGCAGTTCCGCGATGCCGATCAAATCGCTCCCGAACGGATGACCTATGTCCAGCGCGCCAGTATCATGAAGTTAGTAACGGCTGATCAAGCGGGAAACTTCCACCCGCAAGATAGGCTTTCACCAACCGACGAAGCAAGCCTTTGGATACAATACCGGGTAATTCTGTCACAAGCAAGATAA	MKRSFLSFLTTSALLALTTTAWAAPTVTVDGQALAFDVPPIIENGRTLVPVRAISTALGANVNWDVATQTVIIQKADNNIRLPLGGQATKNGNPMDLDVPAKIIQDRTMVPLRFVSEALGCHVVWHDSTQTIAITAQAEPQSPSTATKTIDEKDNGKTITRFAFLTKLIKETDLNLNHIRFIKAPVPSDYVTDVPQEASYAHDVVIAGHYNIIDIGQAFRPDDAITREEAALWLVKALESKKGSLMYIQLFQQFRDADQIAPERMTYVQRASIMKLVTADQAGNFHPQDRLSPTDEASLWIQYRVILSQAR	MKLRYLLAAALLMTTASAFGADAPKRLPVNITNKEWLMPFPGFKIVGNMYYVGTYDLGCYLIDTGAGLILVNTGIMGSYPLMKASIESLGFKTSDIKIITATHGHSDHVGDIALFKKDAPGATVYMSERDVESLESGGNFDYRRPAPEGRGGLVYDPIHVDVKTKPGDHIKLGNVDMTVLQAYGHTPGATSFSFQQTDAGKTYNVLIVNMNGINAGVKLLGSPHYPTIVEDFKNTIDMQATYKPDIWVSSHSGQFNLHQVYKPGDAYNPARFGDLAAYQKKIATAKANYEKQLAEERAAAK	103.32	gnl|BL_ORD_ID|100|hsp_num:0	118			540	798	
BGC0000906.1|Heme_18 # 17161 # 17397 # 1 # ID=1_18;partial=01;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.447	BGC0000906.1|Heme_18 	17161	17397	+	Loose	600	25.409	CAR-1	64.29	3006903	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	CAR beta-lactamase	ATGGAGACAACGGCAATCAAGAATTTGCAGGTATTTACCTTAACCGATGAAAAAACCAACCAAATCTATTATGGCTGCAATCAGGAATGGTACACTTCCTTTTGGAGACGCCTTTCCGGGTGCGGTCCTTCCACCGCCTGCAATATCCTTTTTTATCTTTACCAGACCCGAATGGCCGGTGAGAAGGCCAAAAGATTCCATAATAAAGCCAACTGTGTAGCCTGGATGAACGAAGTA	METTAIKNLQVFTLTDEKTNQIYYGCNQEWYTSFWRRLSGCGPSTACNILFYLYQTRMAGEKAKRFHNKANCVAWMNEV	MKNQRLTPLAAFLLLISVAATAHTLPSQGTETKGAETNSPAITSLTGCGPSSAINQFFNQFGSSGKMPAELGRWLNDAKAQAVEPYQVFDNVYYVGICWVSAWLIKTSEGPVLIDTLYGEFTDQLMDNIKKIGVEPSDIKMVLLTHGHFDHVGGVSKLKSLTNARFVMSEEGWKEAQADAKKTLGKPSAWAMPDPATTDILVKDGDALTVGDTTFHAYITPGHTWGTTSYVLDVKERNNTYHAITIGGLGLNAIDGPQQVEAYIRSIDRIKVMVEDSKHPITVHLTAHPFSNGQIEMQNQLKVHQPDQPHPMVDAKGLLKQLATLRAGAIERLAVEQARIQK	23.10	gnl|BL_ORD_ID|3339|hsp_num:0	4408			132	174	
